trial · primary record
Pyridoxal Phosphate
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2027-09 |
| Primary endpoint | Overall survival time (time to death), including incidence of death at 12 months |
| Registry ID | NCT04706013 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:19.660Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04706013
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.